⌘K
Loading ticker…
As of 2026-08-24, Vivos Therapeutics, Inc. Common Stock (VVOS) has a 3-month relative strength percentile of 5 within the TickerStance CS+ADRC universe (~5,000 tickers). Its Power rating (absolute 1–99) is 25. The current market Stance is 47.8 (Neutral). Sector: Healthcare, ranked 3 of 11. Average daily range 11.5%, relative volume 0.08×. TickerStance reports observed regime conditions across the full CS+ADRC universe; band assignment reflects current breadth, momentum, and macro inputs computed at the daily close. Percentile ranks run from 1 (weakest) to 99 (strongest) relative to all universe members on the same date.
VVOS is in a stage 4 downtrend, week 12. Extended from base. VCP detected: inconclusive. Distance from 50d / 200d: -32.3% / -77.5%.
Relative strength across horizons plus the leadership score.
Accumulation rating, relative volume, U/D ratio, breakout-day proof.
Daily range, ATR, beta, and the math for a 1-ADR stop.
Diluted EPS, last 8 quarters. Loss makers are judged by progress toward breakeven.
YoY sales growth, last 8 quarters. Sales must back the earnings story.
TTM operating margin. Expansion = real operating leverage.
YoY common shares outstanding. Down = buyback tailwind. Up > 2% = dilution flag.
Reported figures from SEC filings. No analyst estimates or forward guidance.
Weak relative strength and quiet attention. Little to read here either way.
Measures how unusual this name’s public attention is against its own 90-day history — a surprise reading, not a ranking of how watched it is versus other stocks. Intel, not a signal.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | VVOS Jan avg: 25.68% median: -13.83% win: 25% σ: 97.94% n: 4 2022-04-12 → 2026-07-31 | VVOS Feb avg: -22.84% median: -17.37% win: 0% σ: 14.64% n: 4 2022-04-12 → 2026-07-31 | VVOS Mar avg: -23.63% median: -17.37% win: 0% σ: 13.66% n: 4 2022-04-12 → 2026-07-31 | VVOS Apr avg: -18.30% median: -12.18% win: 20% σ: 21.09% n: 5 2022-04-12 → 2026-07-31 | VVOS May avg: -3.29% median: -12.52% win: 40% σ: 16.16% n: 5 2022-04-12 → 2026-07-31 | VVOS Jun avg: -0.22% median: 6.22% win: 60% σ: 34.15% n: 5 2022-04-12 → 2026-07-31 | VVOS Jul avg: -4.59% median: -9.79% win: 40% σ: 28.88% n: 5 2022-04-12 → 2026-07-31 | VVOS Aug avg: 2.78% median: 3.48% win: 75% σ: 13.18% n: 4 2022-04-12 → 2026-07-31 (current) | VVOS Sep avg: -25.70% median: -25.98% win: 0% σ: 17.86% n: 4 2022-04-12 → 2026-07-31 | VVOS Oct avg: -10.65% median: -10.11% win: 25% σ: 18.76% n: 4 2022-04-12 → 2026-07-31 | VVOS Nov avg: 163.90% median: 11.46% win: 50% σ: 334.05% n: 4 2022-04-12 → 2026-07-31 | VVOS Dec avg: -13.30% median: -14.89% win: 25% σ: 30.93% n: 4 2022-04-12 → 2026-07-31 |